Login

Kadans set to take on 600,000-square-foot-plus Cambridge life sciences and offices development

IQHQ had secured a position as development partner in 2021
There has been slow progress on the development site. (Getty Images)
There has been slow progress on the development site. (Getty Images)
CoStar News
January 16, 2025 | 9:07 AM

Kadans Science Partner, the AXA IM Alts-backed life sciences real estate specialist, is in advanced talks to take on American group IQHQ's debut project in the UK, a proposed £200 million labs and offices development in Cambridge.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE